Biomanufacturing Excellence Act of 2025

This bill would require the Director of the National Institute of Standards and Technology (NIST) to pick one non-federal group, such as a university or public-private partnership, through a competition to set up and run a National Biopharmaceutical Manufacturing Center of Excellence. The center would work on ways to make medicines from living cells, improve manufacturing methods and supply chains, and train workers for the biotechnology field. Funding could pay for building facilities, research, and training programs. The Director would have to send progress reports to Congress and post them online, and the bill authorizes $120 million for fiscal year 2026.

Full text and official record on Congress.gov

Sponsors

• Christopher A. Coons Democrat sponsor
• 5 cosponsors